To Achieve Maximum Results Dermalogix In Conjunction With Our Medical Staff Strongly Recommends Patients Begin Their Treatments By Starting With Our Prescription Strength Formula
Dermalogix Partners, Inc. patented formulation of medicated, maximum strength DermaZinc™ Cream over the counter (OTC) is recommended for use on the face and other sensitive areas for patients whose skin is sensitive to alcohol, which acts as a vehicle in DermaZinc™Spray/Drops. DermaZinc™Cream is extremely effective in treating red flaky, itchy, scaly skin associated with mild to moderate cases of eczema, psoriasis, and seborrheic dermatitis. Many patients have reported successful results using DermaZinc™ Cream for treating acne and fungal conditions. It is also safe to use on pediatrics that suffer from diaper rash as well as cradle cap.
Easy-to-use DermaZinc™Cream features a high emollient base for skin moisturizing and 0.25% zinc pyrithione. DermaZinc™ Cream is non-oily, has no lingering odor and is safe to use daily. To achieve maximum results we recommend DermaZinc™Cream to be applied twice daily on affected areas.
PATIENTS* suffering with severe cases of eczema, psoriasis, and seborrheic dermatitis, we recommend our patented prescription strength DermaZinc™ Cream. DermaZinc™ Cream compounded with 77mg of Micronized Betamethasone Diproprionate USP. prescribed by your doctor, used twice daily for up to two weeks. Once skin is cleared, maintain clearance by using OTC DermaZinc™ products a minimum of three times a week.
Pharmacist and Doctors, please see compounding instructions or call 1-800-753-0047 ext.4 for more information. To achieve maximum results, Micronized Powder Betamethasone Diproprionate USP should be used
Dermalogix Partners, Inc. recommends using our compounded prescription strength products only to clear chronic skin conditions. Maintain condition by using OTC products a minimum of three times a week to keep condition under control. DermaZinc™ is not a cure, if condition returns, repeat prescription and maintenance process again.
Caution, slight stinging may occur on application if applied on open lesions.
* Not recommended for use on children under the age of 12 unless directed by a doctor. As always with children close monitoring is advisable.